Olga Mikhailovna
Olga Mikhailovna Ipatova, Moscow RU
Patent application number | Description | Published |
---|---|---|
20100179100 | MEDICINAL FORMS OF PHOSPHOLIPID PREPARATIONS AND METHODS FOR THEIR PREPARATION - A method for producing a pharmaceutical composition comprising a combination of phospholipid and glycyrrhizic acid or a pharmaceutically acceptable salt thereof, which composition is hydratable to produce an injectable medicinal form, said method comprising subjecting a mixture of phospholipid and an aqueous solution of glycyrrhizic acid or a pharmaceutically acceptable salt thereof and a carbohydrate to homogenization, for example at 800-1200 bar pressure at a temperature of less than 90° C., and subjecting the product of the homogenization to a sublimation drying step to produce said composition. Compositions obtainable using this method, and hydrated forms of these ready for administration by injection form further aspects of the invention. | 07-15-2010 |
20100222291 | MEDICINAL FORMS OF PHOSPHOLIPID PREPARATIONS AND METHODS FOR THEIR PREPARATION - A method for producing an encapsulated medicinal form of a combination of phospholipid and glycyrrhizic acid or a pharmaceutically acceptable salt thereof, said method comprising mixing a solution of phospholipid in an organic solvent with glycyrrhizic acid or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier substance or additive, granulating the resultant mixture, and encapsulating the resultant product, for example after grinding with a pharmaceutically acceptable carrier substance or additive. Products obtained by this method form a further aspect of the invention, and are useful in the treatment or prevention of diseases associated with liver disorders. | 09-02-2010 |
Olga Mikhailovna Posokhova, Angarsk RU
Patent application number | Description | Published |
---|---|---|
20100196260 | CATALYST FOR VAPOUR CONVERSION OF CARBON MONOXIDE METHODS FOR THE PRODUCTION AND FOR THE USE THEREOF - The invention relates to producing hydrogen by means of the vapour conversion of carbon monoxide and a catalyst for said process and can be used in different industries. The invention discloses an iron-chromium catalyst containing an iron-chromium hydroxyl compound phase having a goethite and/or hydrohematite structure, a method for the preparation thereof and a method for the use thereof in a process for the vapour conversion of carbon monoxide. The catalyst can also contain copper. The catalyst is obtainable by precipitating sodium and potassium, by means on solutions of carbonates or ammonia hydroxides, from solutions of mixture of iron 2+ and 3+ and chromium 3+ nitrates which are obtained by the oxidation-reduction interaction of metal iron, chromium 6+ compounds and nitric acid. A process for the vapour conversion of carbon monoxide using said catalyst according to the inventive method is carried out at a temperature greater than 250° C. Said invention makes it possible to produce a catalyst having low sulphur (equal to or less than 0.03 mass %) and chromium 6+ (equal to or less than 0.05 mass %) contents and exhibiting a high activity at temperatures of 350° C. and less. | 08-05-2010 |
Olga Mikhailovna Suvorova, St. Petersburg RU
Patent application number | Description | Published |
---|---|---|
20090123621 | Feed additive and a method for the production thereof - The method for producing the feed additive based on the processed conifer needle extracts, which is unique, because it uses the microgranulation of the neutralized conifer needle extract and a water-soluble polymer matrix/binding agent in the form of an aqueous solution, which is combined with the extract; this mixture is then added dropwise to an aqueous solution of a crosslinking agent, whereby sodium alginate or a protein/anionic polysaccharide complex, consisting of gelatin and sodium alginate, is used as the polymer matrix/binding agent, and water-soluble calcium salts are used as the crosslinking agent (the calcium salts ensure the obtainment of an insoluble matrix of microgranules), or a protein/anionic polysaccharide complex, consisting of gelatin and sodium alginate, is used as the polymer matrix/binding agent and water-soluble iron salts are used as the crosslinking agent (the iron salts ensure the obtainment of an insoluble matrix of microgranules). | 05-14-2009 |